The effects of conjugated linoleic acid (CLA) on growth performance, non-specific immunity, antioxidant capacity, lipid deposition and related gene expression were investigated in the large yellow croaker (Larmichthys crocea). Fish (7·56 (SEM 0·60) g) were fed soyabean oil-based diets with graded levels of CLA (0, 0·42, 0·83, 1·70 %) for 70 d. Quantitative PCR was used to assess the effects of CLA on the transcription of inflammation-and fatty acid oxidation-related genes. Growth in fish fed the diet with 0·42 % CLA was significantly higher. Also, phagocytic index and respiratory burst activity were significantly higher in fish fed the diets containing 0·42 and 0·83 % CLA, respectively. Hepatic total antioxidative capacity and catalase activities increased significantly when CLA increased from 0 to 0·83 %, and then decreased with further increase of CLA. However, hepatic malondialdehyde content decreased significantly as dietary CLA increased. Lipid concentration in the whole body and muscle increased significantly with increasing dietary CLA. Transcription of genes related to inflammation (cyclo-oxygenase-2 and IL-b) in the liver and kidney and fatty acid oxidation (carnitine palmitoyl transferase I and acyl CoA oxidase) in the kidney decreased significantly as dietary CLA increased. PPARa and acyl CoA oxidase expression in the liver decreased significantly as CLA increased from 0·42 to 1·70 %. These results strongly suggest that dietary CLA could significantly affect growth performance, non-specific immunity, antioxidant capacity, lipid deposition and transcription of inflammation-and fatty acid oxidation-related genes of the large yellow croaker. This may contribute to our understanding of the mechanisms related to the physiological effects of dietary CLA in fish.
Conjugated linoleic acid (CLA) is a collective term for isomers of linoleic acid (18 : 2n-6) and the two main isomers are cis-9, trans-11 and trans-10, cis-12 (1) . In mammals, CLA has been shown to exert potential health benefits related to its antioxidative, anticarcinogenic, immunomodulative and diabetes-modulator properties in addition to decreasing body fat deposition (2 -4) . In the last decade, studies have been conducted to investigate the effects of CLA on growth performance, liver lipid deposition, non-specific immunity as well as deposition of this fatty acid in a variety of freshwater fish species including channel catfish (Ictalurus punctatus), tilapia (Oreochromis niloticus), rainbow trout (Oncorhynchus mykiss) and yellow catfish (Pelteobagrus fulvidraco), and some euryhaline fish species, such as sea bass (Dicentrarchus labrax), yellow perch (Perca flavescens) and Atlantic salmon (Salmo salar) (4 -11) . It has been shown that fish are capable of accumulating high levels of CLA in their tissues when diets are supplemented with this particular fatty acid (12) . However, as for growth performance and liver lipid deposition, results vary significantly among different fish species. It has been shown that growth performance is not significantly affected by the inclusion of CLA up to 1 % in juvenile sea bass (4) and Atlantic salmon (10) , or 2 % in channel catfish (7) . However, growth performance was significantly decreased by CLA at the level of 1 % in hybrid striped bass (Morone saxatilis £ Morone chrysops) (6) and yellow catfish (11) , and by 2 % in gilthead sea bream (Sparus aurata L.) (1) and tilapia (13) . Growth-promoting effects by dietary CLA have also been reported, with weight gain of common carp (Cyprinus carpio) and channel catfish increased by the level of 1 % CLA (14, 15) . Similar variation has been found in lipid deposition in response to increasing dietary CLA (9 -11) . Furthermore, little information is available about the effects of dietary CLA on non-specific immunity and antioxidant capacity in fish species (4) .
Previously, mechanisms related to the physiological effects of CLA have not been completely elucidated in any animal models. In mammals, dietary CLA can decrease oxidative stress and over-inflammation through suppressing the production of pro-inflammatory cytokines such as IL-2 and TNF-a as well as phospholipid-derived hormones, for example, eicosanoids (16 -19) . CLA has also been found to exert physiological effects by modulating NF-kB, which controls important cell signalling, phosphorylates certain transcription factors and subsequently activates relevant gene expression (20 -22) . However, to our knowledge, no information is available about the effects of dietary CLA on the expression of genes related to inflammation and fatty acid oxidation under a formulation with constant n-3 highly unsaturated fatty acids (HUFA) and n-3:n-6 PUFA in any fish species. Cyclo-oxygenase-2 (COX-2) is a key biosynthetic enzyme in the synthesis of prostaglandins, such as PGE 2 . It has been shown that COX-2 is dramatically up-regulated during pathological conditions, such as inflammation and cancer (23) . Proinflammatory cytokines, IL-1b and TNF-a, are key regulators of the immune system that shapes innate and adaptive immune responses (24) . An adequate balance of the cytokine environment is critical to achieve protective immunity and to avoid immunopathology (24 -26) .
PPARa, carnitine palmitoyl transferase I (CPT1) and acyl CoA oxidase (ACO) participate in fatty acid oxidation and their expression levels could reflect the oxidative stress inside cells to some extent (27) . Previous studies have investigated the relationship between the transcription of these genes and lipid metabolism (1, 28) . It was shown that transcription of PPARa could increase in the liver of the large yellow croaker as well as the muscle and adipose tissue of gilthead sea bream as dietary CLA increased from 0 to 4 % (1, 28) . However, little attention has been paid to the role of fatty acid oxidation-related genes in control of oxidative stress in fish species. Since inflammation, immune function and state of oxidative stress have been found to be closely correlated (29, 30) , there is great interest to investigate the mRNA expression of fatty acid-related genes (PPARa, CPT1 and ACO) in both the liver and kidney of large yellow croaker fed diets with graded levels of CLA.
The large yellow croaker (Larmichthys crocea) is an important marine fish species that is widely cultured in southeast China. During the past few years, studies on the nutrition of this fish have been conducted intensively (31 -35) . However, as far we know, little information is available about the effects of fatty acid nutrition on immune function, antioxidant capacities and lipid deposition, especially mechanisms involved in these processes for this fish species. Thus, the pre-sent study was conducted to investigate the effects of dietary CLA on growth performance, selected immunological parameters, antioxidant capacity and lipid deposition as well as on the expression of inflammation-and fatty acid oxidationrelated genes in the large yellow croaker.
Materials and methods

Feed ingredients and diet formulation
Four isoproteic (42 % crude protein) and isolipidic (12 % crude lipid) diets were formulated to contain graded levels of CLA (0, 0·42, 0·83 and 1·70 % dry diet) by adding different amounts of CLA-enriched oil (18 : 2 cis-9, trans-11: 38·86 % total fatty acids (TFA); 18 : 2 cis-10, trans-12: 32·91 % TFA; Aohai Biotechnology Co., Ltd). Then soyabean oil (China Oil and Foodstuffs Corp.) was added to a final amount of 7·0 % oil mixture of dry diet. The optimal n-3 HUFA level (about 0·8 % dry diet) was guaranteed by supplementing 30 % white fishmeal (crude protein 74·3 % DM, crude lipid 6·6 % DM; Great Seven Biotechnology Co., Ltd) and 2·0 % fish oil (arachidonic acid (ARA) content, 0·23 % TFA; EPA content, 13·34 % TFA; DHA content, 10·53 % TFA; Great Seven Biotechnology Co., Ltd) in each diet according to the results of our previous study (36) . White fishmeal and soyabean meal (crude protein 49·4 % DM, crude lipid 0·9 % DM; Great Seven Biotechnology Co., Ltd) were included as the main protein sources. Ingredients and nutrient composition of the four experimental diets are given in detail in Tables 1 and 2. All ingredients were ground into fine powder so that they passed through a 246 mm screen. Ingredients of each diet were blended thoroughly first by hand and then mechanically. The oil mixture was then thoroughly mixed with all ingredients of each diet, after which water (200 g/kg) was added to make stiff dough. Pellets (4 £ 5 mm and 5 £ 5 mm) were made using an automatic pellet-producing machine (Weihai) and dried for about 12 h in a ventilated oven at 408C. After drying, feeds were packed in double plastic bags and stored at 2208C until used.
Fish rearing and sampling
Fish rearing and sampling were carried out according to the experimental procedures of the key laboratory of mariculture (Ministry of Education of China), Ocean University of China. Large yellow croaker were bought from a commercial farm in Xiangshan Bay, Ningbo, China. Before the start of the experiment, juveniles were reared in floating sea cages (3 £ 3 £ 3 m) and fed the control diet for 2 weeks to acclimatise to the experimental conditions and feeds.
At the start of the experiment, the fish were fasted for 24 h and weighed after being anaesthetised with eugenol (1:10 000) (Shanghai Reagent). Fish of similar sizes (7·56 (SEM 0·60) g) were distributed into twelve sea cages (1 £ 1 £ 1·5 m), and each cage was stocked with sixty fish. Each diet was randomly allocated to triplicate cages of fish. Fish were hand-fed twice daily (05.00 and 17.00 hours) to apparent satiation. The feeding trial lasted for 70 d. During the experimental period, water temperature, salinity and dissolved O 2 were measured daily. The water temperature ranged from 24 to 308C, and salinity from 32 to 36‰. The dissolved O 2 was approximately 7 mg/l. At the termination of the experiment, fish were fasted for 24 h before harvest. Then, experimental fish in each cage were weighed one by one and final fish number was recorded after they were anaesthetised with eugenol as described above. After that, blood samples were obtained from the caudal vein of five fish from each cage with 27-gauge needles and 1 ml syringes and allowed to clot at room temperature for 4 h and then at 48C for a further 6 h. The clot was removed and residual blood cells were separated from the straw-coloured serum by centrifugation (836 g; 10 min; 48C). The serum was frozen in liquid N 2 and then stored at 2 808C for later analysis of lysozyme activity. Livers and kidneys from five fish in each cage were pooled into 1·5 ml tubes (RNAase-Free; Axygen), frozen in liquid N 2 and then stored at 2 808C for later analysis of gene expression related to inflammation and fatty acid oxidation. Liver and muscle from another ten fish in each cage were pooled into 10 ml tubes, frozen in liquid N 2 and then stored at 2 808C for the assay of fatty acid composition, moisture and crude lipids. Whole bodies of six fish in each cage were collected into plastic bags and then stored at 2 208C for the assay of moisture and crude lipids.
Biochemical analysis
Crude protein was determined by digestion using the Kjeldahl method (Kjeltec FOSS 2300; Tecator) and estimated by multiplying N by 6·25. Crude lipid was measured by ether extraction using the Soxhlet method (Soxhlet Extraction System B-811). Fatty acid profiles were analysed using the procedures described by Metcalfe et al. (37) with some modification (33) . About 100 mg freeze-dried samples/50 ml oil were added into a 20 ml volumetric screwed tube with a cover. Then 3 ml potassium hydroxide methanol (1 M) were added and heated in a 728C water-bath for 20 min. After that, 3 ml hydrogen chloride methanol (2 M) were added and the mixture was heated in a 728C water-bath for another 20 min. Previous tests were conducted to make sure that all fatty acids could be esterified following the procedures above. Finally, 1 ml hexane was added into the mixture above, shaken vigorously for 1 min, and then allowed to separate into two layers. Fatty acid methyl esters were separated, and quantified by a HP6890 gas chromatograph (Agilent Technologies Inc.) with a fused silica capillary column (007-CW; Hewlett Packard) and a flame ionisation detector. The column temperature was 
Functional immune assays
Phagocytic index. Phagocytic index (PI) was measured according to the method of Pulsford et al. (38) with some modification. Head kidneys of six fish per cage were removed, homogenised in the modified formula of L-15 culture medium (10 mg/ml heparin; 200 U/ml penicillin/streptomycin; 15 mM-HEPES; 1 % fetal bovine serum) and then filtered through a 100 mm nylon mesh. The resulting cell suspensions were enriched by centrifugation (836 g, 25 min, 48C) on a 34 %/51 % Percoll (Pharmacia) density gradient. The cells were collected at the 34 -51 % interface and washed twice using L-15 culture medium above. Then 100 ml cell suspensions were stained with 100 ml trypan blue (0·4 %; Sigma) at 23·58C for 1 min, and then detected under a microscope (40 £ ) to determine the cell concentration and viability. The cell viability was more than 95 % and final cell concentration was adjusted to approximately 1 £ 10 7 leucocytes/ml. Then 100 ml cell suspensions of head kidney leucocytes and 100 ml yeast suspension (Bakers yeast, Type II, Sigma; 1 £ 10 8 cells/ml) were mixed into a 2 ml-sized plastic tube and cultured at 23·58C for 40 min. To calculate the PI, a sample of mixture was put into the blood cell counting plate (Shanghai Qiujing Biochemical Reagent and Apparatus Co., Ltd) and 200 cells were counted where the number of cells with ingested yeasts was recorded. Respiratory burst activity. Production of intracellular superoxide anion (O 22 ) for five fish from each cage was evaluated using nitroblue tetrazolium (NBT) (Sigma) reduction following the method of Secombes (39) with some modifications. A 100 ml cell suspension was stained with 100 ml NBT (1 mg/ml) and 100 ml phorbol 12-myristate 13-acetate (PMA; 1 mg/ml; Sigma) which was used as a trigger for O 22 production for 45 min. Absolute methanol was added to terminate the staining. Each tube was washed three times with 70 % methanol and air-dried. Then, 120 ml 2 M-KOH and 140 ml dimethyl sulfoxide (DMSO) were added and absorbance was measured at 630 nm with a spectrophotometer using KOH/DMSO as a blank.
Lysozyme activity. Lysozyme activity in serum was measured according to the method of Ellis (40) . Briefly, a sample of 0·05 ml serum was added to 1·4 ml of a suspension of Micrococcus lysodeikticus (Sigma) (0·2 mg/ml) in a 0·1 M-sodium phosphate buffer (pH 6·8). The reaction was carried out at 258C and absorbance was measured at 530 nm after 0·5 and 4·5 min in a spectrophotometer. Each unit is defined as the amount of sample causing a decrease in absorbance of 0·001/min.
Hepatic antioxidative capacity assays. Liver samples were first ground into powder in liquid N 2 and then homogenised in nine volumes of ice-cold phosphate solution (pH 7·4) and centrifuged at 4000 g for 10 min at 48C. After that, the supernatant fraction was determined for soluble protein by the method of Bradford (41) using bovine serum albumin as standard and then stored at 2 808C until use.
Total antioxidative capacity. Total antioxidative capacity was assayed using a commercial kit (Nanjing Jiancheng Bio-engineering Institute). Briefly, Fe 3þ can be reduced to Fe 2þ under some antioxidative enzyme systems and Fe 2þ can combine with phenanthroline. Absorbance was read at 520 nm, with distilled water as blanks. Results are expressed in units of total antioxidative capacity per mg soluble protein and each unit is defined as the amount of enzyme that can increase the absorbance by 0·01 in 1 min at 378C.
Catalase activity. Hepatic catalase (CAT) was assayed using a commercial kit (Nanjing Jiancheng Bio-engineering Institute). CAT reacts with H 2 O 2 for exactly 1 min and then ammonium molybdate was quickly added to stop the reaction (42) . The remaining H 2 O 2 can react with ammonium molybdate and generate a light-yellow complex. The CAT activity can be calculated by assaying the absorbance at 405 nm, with distilled water as blanks. Results are expressed in units of CAT per mg soluble protein and each unit is defined as the amount of enzyme necessary to resolve 1 mmol H 2 O 2 in 1 s at 378C.
Superoxide dismutase activity. Superoxide dismutase activity was measured spectrophotochemically by the ferricytochrome c method using xanthine/xanthine oxidase as the source of superoxide radicals. The reaction mixture consisted of 50 mm-potassium phosphate buffer (pH 7·8), 0·1 mM-EDTA, 0·1 mM-xanthine, 0·013 mM-cytochrome c and xanthine oxidase (0·024 IU/ml). The reaction was triggered by the addition of the xanthine oxidase. Results are expressed in units of superoxide dismutase per mg soluble protein and each unit is defined as the amount of enzyme necessary to produce 50 % inhibition of the ferricytochrome c reduction rate measured at 550 nm (43) .
Malondialdehyde content. Malondialdehyde (MDA) as one of the metabolites derived from lipid peroxidation was measured using the thiobarbituric acid (TBA) assay kit (Nanjing Jiancheng Bio-Engineering Institute). MDA reacts with TBA to produce a pink-coloured material that can readily be monitored by a spectrophotometer to give an overall indication of the level of lipid peroxidation (44) . Generally speaking, 100 ml supernatant fraction of liver homogenates in each replicate were incubated with 20 % TCA and 0·67 % TBA at 958C for 40 min. Absorbance was read at 532 nm, with distilled water as blanks. Results were converted to nmol MDA per mg soluble protein using a standard sample of 10 nmol/ml malonaldehyde diethyl acetate.
RNA extraction and real-time quantitative PCR
Total RNA was extracted from the liver and kidneys using Trizol Reagent (Invitrogen) and electrophoresed on a 1·2 % denaturing agarose gel to test the integrity. The RNA was treated with RNA-Free DNase (Takara) to remove DNA and reverse transcribed to complementary DNA (cDNA) by a Pri-meScript TM RT Reagent Kit (Takara) following the instructions. First-strand cDNA was diluted by four times using sterilised double-distilled water. Real-time quantitative PCR was carried out in a quantitative thermal cycler (Mastercycler w ep realplex; Eppendorf). The amplification was performed in a total volume of 25 ml, containing 1 ml of each primer (10 mM), 1 ml of the diluted first-strand cDNA product, 12·5 ml of 2 £ SYBR w Premix Ex Taq TM II (Takara) and 9·5 ml of sterilised double-distilled water. The real-time PCR programme was as follows: 958C for 2 min, followed by forty cycles of 958C for 10 s, 588C for 10 s, and 728C for 20 s. The primer sequence for b-actin, COX-2, IL-1b, TNF-a, PPARa, CPT1 and ACO were designed following the published sequences for the large yellow croaker from GenBank or published papers (28, 45, 46) and listed in Table 3 . PCR fragments amplified by each pair of primers were sequenced, blasted and analysed to assure the specificity of each primer pair. At the end of each PCR reaction, melting curve analysis was performed to confirm that only one PCR product was present in these reactions. Standard curves were made with five different dilutions (in triplicate) of the cDNA samples and amplification efficiency was analysed according to the following equation E ¼ 10 (2 1/slope) -1. The primer amplification efficiency was 1·020 for b-actin, 1·004 for COX-2, 0·9954 for IL-1b, 1·0188 for TNF-a, 0·9924 for PPARa, 1·1190 for CPT1 and 1·0813 for ACO. The absolute DC T (cycle threshold) values between the target gene and inner control gene were all close to zero and indicate that the DDC T calculation for the relative quantification of target genes can be used. To calculate gene expression, the comparative CT method (2 2DDT method) was used as described by Yao et al. (46) .
Calculations and statistical analysis
Growth parameters were calculated as follows:
Survival rateð%Þ¼100 £ ðfinal fish number=initial fish numberÞ: 
Results
Survival rate, growth performance and somatic indices
Survival rate of large yellow croaker for all dietary treatments was above 91·0 % and there were no significant differences among dietary treatments in the present study (P.0·05). No statistical differences were detected in feed intake among dietary treatments (19·11 -20·74 g/kg average body weight per d) (P. 0·05). As dietary CLA increased from 0 to 0·42 %, weight gain rate increased significantly from 499·30 to 572·52 % (P, 0·01), and then decreased to 444·21 % with dietary CLA increasing from 0·42 to 1·70 % (P, 0·05). No significance was detected in the feed efficiency ratio of experimental fish among dietary treatments (P. 0·05). The viserosomatic index of fish fed the 0·42 % CLA diet (6·79 %) was significantly higher than that of fish in the control (6·06 %) and 1·70 % CLA treatment (6·27 %) groups (P, 0·05). Hepatosomatic index significantly increased from 1·40 to 1·93 % with the increase of dietary CLA (P,0·05) ( Table 4 ).
Immunological and hepatic antioxidative parameters
As dietary CLA increased from 0 to 0·42 %, PI increased significantly from 17·9 to 34·7 %, and then decreased to 24·7 % with dietary CLA increasing from 0·42 to 1·70 % (P,0·05). Respiratory burst activity (value of optical density (OD) 630) showed a similar trend to PI as dietary CLA increased. Respiratory Table 3 . Real-time quantitative PCR primers for inflammation-and fatty acid oxidation-related genes and b-actin of the large yellow croaker (Larmichthys crocea)
Gene
Nucleotide sequence ( burst activity was significantly increased by 0·83 % CLA (OD630 ¼ 0·50) compared with the control (OD630 ¼ 0·34) and 1·70 % CLA treatment (OD630 ¼ 0·42) groups (P, 0·05). However, no significant differences were observed in this parameter between the control and the 1·70 % CLA groups (P.0·05). There were no statistical differences in serum lysozyme activity among four dietary treatments (P. 0·05) ( Table 5 ). Total antioxidative capacity increased significantly from 0·29 to 2·14 units/mg protein as dietary CLA increased from 0 to 0·83 %, and then decreased significantly to 1·22 units/mg protein with further increase of CLA (P, 0·05). Hepatic CAT increased significantly from 36·46 to 71·45 units/mg protein as dietary CLA increased from 0 to 0·83 %, and then decreased significantly to 32·58 units/mg protein with further increase of CLA (P, 0·05). Superoxide dismutase activity in the liver increased from 21·68 to 29·64 units/mg protein as dietary CLA increased from 0 to 0·42 % and then decreased to 18·95 units/mg protein with further increase of this fatty acid (P. 0·05). MDA content in the liver decreased significantly from 3·30 to 1·66 nmol/mg protein with the increase of dietary CLA (P,0·05) ( Table 5 ).
Proximate composition of whole body, muscle and liver
No significant difference was detected in moisture content of the whole body, liver and muscle (P. 0·05). The lipid content of the whole body and muscle increased significantly with the increase of dietary CLA (P, 0·05). The whole body lipid content of fish fed the diets with 1·70 % CLA (8·51 % wet weight) was significantly higher compared with the control (7·44 % wet weight) and 0·42 % CLA treatment (7·38 % wet weight) groups (P, 0·05). The muscle lipid content of fish fed the diets with 0·83 % CLA (7·26 % wet weight) was significantly higher compared with the control (5·97 % wet weight) and 0·42 % CLA treatment (5·47 % wet weight) groups (P,0·05). There were no significant differences in liver lipid concentration among dietary treatments (P.0·05) ( Table 6 ).
Liver and muscle fatty acid profiles
Deposition of CLA isomers, 18 : 2 cis-9, trans-11 and 18 : 2 trans-10, cis-12, were increased with the increase of dietary CLA (P,0·05). Dietary CLA modified significantly the retention of SFA, MUFA and ARA in the liver. The total percentage of SFA, mainly 14 : 0, 16 : 0 and 18 : 0, increased with dietary CLA increasing to 0·42 %, and then decreased with further increase of CLA. The hepatic concentration of 16 : 0 in the 0·83 % CLA treatment group (18·97 % TFA) was significantly higher than that in the control (16·78 % TFA) and 1·70 % CLA treatment (16·43 % TFA) groups (P,0·05). Hepatic 18 : 0 content in the 0·42 % CLA treatment group (10·64 % TFA) was significantly higher than that in the control group (4·92 % TFA) (P, 0·05). MUFA percentage in the liver decreased by a reduction in 16 : 1n-9 and 18 : 1n-9 as dietary CLA increased 
Mean values within a row with unlike superscript letters were significantly different (P,0·05). (P,0·05). The percentage of ARA increased significantly from 1·64 to 2·72 % TFA as dietary CLA increased. The ARA:EPA ratio increased significantly from 1·11 to 2·79 with the increase in dietary CLA. There were no significant differences in the content of n-3 HUFA or the ratio of DHA:EPA among dietary treatments (P. 0·05) ( Table 7) . For muscle, the concentration of biologically active isomers, 18 : 2 cis-9, trans-11 and 18 : 2 trans-10, cis-12, increased significantly with increasing dietary inclusion of CLA (P,0·05). The content of SFA in muscle increased, while MUFA decreased as dietary CLA increased (P, 0·05). The 18 : 0 content of muscle in the 0·83 % CLA treatment group (8·01 % TFA) was comparable with that in the 0·42 % CLA (6·40 % TFA) and 1·70 % CLA (6·70 % TFA) treatment groups, but significantly higher than that in the control treatment group (4·64 % TFA) (P,0·05). ARA increased significantly from 1·93 to 2·61 % TFA as dietary CLA increased. The ARA:EPA ratio increased significantly from 0·65 to 0·87 with the increase in dietary CLA. No significant differences were detected in the concentration of n-3 HUFA or the DHA:EPA ratio among dietary treatments (P. 0·05) ( Table 8 ).
Expression of inflammation-and fatty acid oxidationrelated genes
The transcriptional levels of COX-2 and IL-1b in the liver and kidney decreased significantly with increasing dietary CLA. Hepatic COX-2 mRNA expression level was significantly decreased by approximately 0·30-fold, 0·67-fold and 0·72-fold in the 0·42, 0·83 and 1·70 % CLA treatment groups, respectively (P, 0·05) ( Fig. 1(A) ). The kidney COX-2 mRNA transcriptional level was significantly decreased by about 0·60-fold, 0·70-fold and 0·85-fold in the 0·42, 0·83 and 1·70 % CLA treatment groups than that in the control group, respectively (P, 0·05) ( Fig. 1(B) ). IL-1b mRNA levels of fish fed diets with 0·83 and 1·70 % CLA were significantly decreased by about 0·90-fold in the liver and 0·60-fold in the kidney compared with the control group, respectively (P, 0·05) ( Fig. 1(A) and (B) ). There were no significant differences in the transcription of TNF-a in the liver and kidney among dietary treatments (P. 0·05) ( Fig. 1(A) and (B) ).
Hepatic PPARa transcriptional levels increased significantly to the maximum levels with dietary CLA increasing from 0 to 0·42 %, and thereafter decreased significantly with further increase of dietary CLA (P, 0·05). mRNA expression levels of PPARa were increased by 0·89-fold in the 0·42 % CLA treatment group while they decreased by 0·1-fold and 0·4-fold in the 0·73 and 1·70 % dietary CLA treatment groups compared with the control treatment. The hepatic transcriptional levels of CPT1 in the 0·83 and 1·70 % CLA treatment groups were about 1·40-fold higher than those of the control and 0·42 % CLA treatment groups. The ACO transcriptional levels in the liver of fish fed diets with equal to or above 0·42 % CLA were decreased by more than 0·50-fold compared with the control group (Fig. 2(A) ). 1·77  0·13  1·75  0·12  1·73  0·10  1·82  0·04  0·932  16 : 0  16·77  0·57  17·29  0·20  16·96  0·06  16·11  0·16  0·132  18 There was no significant difference in kidney PPARa mRNA expression among dietary treatments, though a decreasing trend was observed as dietary CLA increased (P.0·05). The transcription levels of CPT1 and ACO in the kidney decreased significantly as dietary CLA increased. CPT1 transcriptional levels in the kidney of fish fed diets with equal to or above 0·42 % CLA were significantly decreased by about 0·50-fold compared with the control treatment group (P, 0·05). ACO transcriptional levels in the kidney were decreased by 0·58-fold, 0·47-fold and 0·63-fold in the 0·42, 0·83 and 1·70 % CLA treatment groups, respectively ( Fig. 2(B) ).
Discussion
In the present study, the growth of fish was significantly enhanced by moderate inclusion of CLA (0·42 %), but decreased when the level of this particular fatty acid was equal to or above 0·83 %. The growth-promoting effects of a moderate level of CLA are consistent with the findings in common carp (14) , Pacific white shrimp (47) and channel catfish (15) . On the contrary, some studies have reported the deleterious effects of CLA on the growth performance of fish (6, 8, 11) . Thus, it can be concluded that the effect of CLA on growth performance varies significantly among different species, and this is probably due to different physiological responses to dietary CLA inclusion for different species (11, 12) .
The two non-specific immune parameters, PI and respiratory burst, were significantly higher in fish fed diets with 0·42 and 0·83 % CLA compared with the control and other groups. The poor non-specific immunity of fish fed the control and the highest-CLA diet (1·70 %) could be due to a too high or low inflammation level of the fish body (24, 25) . In the present study, mRNA levels of COX-2 and IL-1b were significantly higher in the liver and kidney of fish fed the control diet with a high amount of linoleic acid (18 : 2n-6) . High inclusion of dietary n-6 fatty acids have been found to exert deleterious effects on the health of gilthead sea bream by influencing fatty acid composition of immune cells with a high deposition of linoleic acid, altering eicosanoid production, and even chronically increasing the basal expression of certain inflammationrelated genes (26,48 -51) . Thus, the relatively higher level of inflammation could account for the low non-specific immunological parameters of fish fed the control diet in the present investigation. Moderate dietary CLA (0·42-0·83 %) could benefit the immunity of fish through modulating inflammation, which is characterised by transcriptional levels of COX-2 and IL-1b, to a relatively optimum level. However, cytokines are key regulators of the immune system that shape innate and adaptive immune responses (24) . Scarce expression of COX-2 and IL-1b could be responsible for the relatively worse fish immunity in treatments with the higher level of CLA. Since a positive control (100 % fish oil-containing diet) was not included in the present study, it is still unknown whether dietary CLA can attenuate inflammation as strongly as fish oil does or whether dietary CLA can improve immune potential. However, it should be admitted that CLA could enhance nonspecific immunity by ameliorating high inflammation (COX-2 and IL-1b) caused by high n-6 fatty acids at least from the results of the present study.
In the present study, no significance was detected in the transcription of TNF-a among dietary treatments. This was inconsistent with the findings of Montero et al. (26) who found that transcription of TNF-a was significantly higher in fish fed diets with 100 % soyabean oil compared with those fed diets with 100 % fish oil, 70 % linseed oil or 70 % soyabean oil. However, it should be noted that transcription of TNF-a was detected at different time points (1 d, 3 d and 7 d) after exposure to a sub-lethal dose of Photobacterium damselae subsp. piscicida in that study. Increased expression of TNF-a and IL-1b after exposure to pathogens has been reported in several fish species (26, 45) . Thus, it is possible that TNF-a was less sensitive than IL-1b to dietary CLA without pathogen challenge. Furthermore, different fish species and diet formulation could also account for the inconsistent results.
On the other hand, the immune enhancement by moderate dietary CLA may benefit from its antioxidant capacity. The antioxidant effect of CLA has been observed in many studies of rodents and human subjects (52 -54) . In the present study, mRNA expression of fatty acid oxidation-related genes in the liver and kidney declined while hepatic antioxidant capacity increased as dietary CLA level increased to 0·83 %. This means that CLA could function as a kind of antioxidant nutrient in the large yellow croaker. Intervention with antioxidant nutrients (vitamin E, vitamin C, b-carotene and carotenoids) has been shown to enhance the immune response in several fish species (31,55 -59) . Antioxidant nutrients are proposed to exert their immune-enhancing effects through suppression of lipid peroxide and/or PGE 2 production according to the findings in mammals (29, 30) . In the present study, the expression of COX-2 and IL-1b generally paralleled well with the transcription of fatty acid oxidation-related genes while showing an antagonistic tendency with hepatic antioxidant capacity as dietary CLA increased. However, hepatic antioxidant capacity was not further enhanced in fish fed the diet with the highest level of CLA, which was in accordance with PI and respiratory burst activity. Reactive oxygen species exert a critical role in bacterial killing after bacteria are ingested by phagocytes (60, 61) . When fatty acid oxidation was inhibited to a very low level, the normal respiratory burst activity (reactive oxygen species production) could be unavoidably damaged.
In the present study, fish fed the control diet were subject to serious inflammation, characterised by a relatively higher transcription of COX-2 and IL-1b, higher expression of fatty acid oxidation-related genes (PPARa, CPT-I and ACO) and MDA production, as well as significantly lower antioxidant capacity. In accordance, the hepatosomatic index and viserosomatic index were significantly lower in fish fed the control diet. This implies that fish fed the diets without CLA (the control) may suffer hepatic injury and toxicity from serious oxidative stress and inflammation. Indeed, hepatic disease caused by inflammation and oxidative stress has been reported in considerable studies on rodents (16) and male Japanese medaka (27) . However, no direct evidence was obtained in the present study, and investigations are needed to verify this hypothesis in further studies.
An increasing lipid content of the whole body and muscle was observed as dietary CLA level increased in the present study. This could result from decreasing fatty acid oxidation, which is reflected by reduced transcription of PPARa, CPT1 and ACO, in response to increasing dietary CLA. However, there were no significant differences in liver lipid concentration among dietary treatments. The present results are in accordance with the findings of Kennedy et al. (10) who found that muscle lipid content of Atlantic salmon increased as dietary CLA increased and support the fact that dietary CLA had no significant effect on the liver lipid content of catfish (7) , Atlantic salmon (10) or rainbow trout juveniles (9) . In contrast, decreased lipid concentration in the whole body or liver was observed in some other studies (5, 6, 9, 11) . The different physiological effects of CLA observed in the present study and other reports may be attributed to differences in metabolic rate, administered dose of CLA, relative proportion of each isomer in a dietary CLA mixture, or duration of the feeding period, as pointed out by Terpstra (62) . Furthermore, different diet formulations may be one important cause for the discrepancies in the effects of dietary CLA on lipid deposition. In the present investigation, soyabean oil was used to balance the total amount of oil mixture, with almost equal amount of n-3 HUFA and ratio of n-3:n-6 PUFA among the four diets. However, in most previous studies, fish oil was used to acquire equal lipid content, and thus n-3 HUFA and ratio of n-3:n-6 PUFA were decreased as dietary CLA increased. The lipid concentration of the whole fish body increased with the increase of dietary n-3 HUFA in gilthead sea bream (63) and large yellow croaker (RT Zuo, QH Ai, KS Mai and W Xu, unpublished results). As dietary n-3:n-6 PUFA increased, body lipid also increased in gilthead sea bream (64) and juvenile yellow catfish (65) . Evidence above indicated that lipiddecreasing effects caused by dietary CLA could be attributed to decreased dietary n-3 HUFA level or n-3:n-6 PUFA in some previous studies.
In the present study, the total percentages of the main fatty acids were strongly affected by the dietary inclusion of CLA. A significant increase of SFA and decrease of MUFA was observed in the liver and muscle of fish fed diets with increasing amounts of CLA. This was similar to the findings of some previous studies on other fish species (11, 66) . Since SFA and MUFA concentrations were equal among experimental diets in the present study, the increased SFA and decreased MUFA in the liver and muscle could be attributed to a low conversion of SFA to MUFA. Indeed, reduced activity of D9 desaturase, a rate-limiting enzyme converting SFA to MUFA, has been found to be suppressed by dietary CLA as pointed out by Valente et al. (12) . EPA and DHA profiles in selected tissues of the present experiment showed no significant differences among dietary treatments. This was consistent with the findings of studies by Makol et al. (4) and Tan et al. (11) , but inconsistent with the results of some other studies where increased EPA and DHA levels were found as dietary CLA increased (6, 12, 67) .
Increased deposition of n-3 HUFA could result from a higher expression of D5 and D6 desaturases that play critical roles in HUFA biosynthesis (9, 68) . In the present study, hepatic ARA concentration increased while COX-2 expression decreased significantly with the increase in dietary CLA. It was possible that more ARA in the liver of fish fed the control diet participated in eicosanoid production catalysed by COX-2 and this resulted in the lower ARA deposition in the control treatment. Although PGE 2 concentration was not assayed in serum or other tissues, it is usually believed that PGE 2 content parallels well with COX-2 transcriptional levels to a large extent (69 -72) .
To conclude, a moderate level of dietary CLA could be beneficial for fish growth performance, non-specific immunity and hepatic antioxidant capacity. In the large yellow croaker, dietary CLA may exert beneficial effects through modulating the mRNA expression of inflammation-related genes (COX-2 and IL-1b) and fatty acid oxidation-related genes (PPARa, CPT1 and ACO). Future studies are needed to investigate the effects of this particular fatty acid on other metabolism processes such as lipid transportation and distribution in the large yellow croaker.
